Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000191089 | SCV000245486 | uncertain significance | Charcot-Marie-Tooth disease type 2D | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000860828 | SCV001000992 | benign | Charcot-Marie-Tooth disease type 2 | 2024-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020306 | SCV002755187 | likely benign | not specified | 2020-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Inherited Neuropathy Consortium | RCV000790259 | SCV000929659 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV000191089 | SCV004174553 | uncertain significance | Charcot-Marie-Tooth disease type 2D | 2016-01-06 | no assertion criteria provided | literature only |